Navigation Links
New MagnaBloc™ Product Available from Gradient Medical
Date:7/2/2008

Gradient Medical recently started offering QuadraBloc™, a new and improved version of AmWay's MagnaBloc.

Memphis, TN (PRWEB) July 2, 2008 -- AmWay's MagnaBloc™, a long-popular form of pain management, is now available in a new, stronger form: QuadraBloc™, offered by Gradient Medical.

"QuadraBloc has already been released in the United States, and will be available worldwide within 60 sixty days," said John Townsend, President of Gradient Medical, LLC. "We will also be releasing several new products within the next few weeks."

Put simply, the QuadraBloc uses magnetic principles to disrupt the transduction of the electrochemical pain signals to the brain. QuadraBloc uses not one but four magnets and a focusing ring placed in a square or diamond pattern. For maximum pain management the QuadraBloc is placed directly over the irritated nerve, where the gradient of the magnetic field has the strongest impact on the nerve's pain signal.

"QuadraBloc is between two and four times stronger than MagnaBloc," Townsend said. "This technology offers an alternative for superior pain relief for people with back pain, sports injuries, and other sources of chronic pain."

The principles that the QuadraBloc is based on were first published in Environmental Science in 1991. In addition, the device's effectiveness is supported by more than a decade of cell research at the Vanderbilt University School of Medicine and at the Center for Pain Research and Neuromagnetics at the University Medical Center in Nashville, Tennessee, as well as numerous other studies performed around the world. To eliminate the experimenters' biases, several of the studies done have been "double blinded," which is where neither the doctor nor the patient know which group the patient is in: the experimental group, which uses the QuadraBloc device, or the control group, which uses a "placebo" or a dummy device.

"The principles used in creating the QuadraBloc have been scientifically researched and well documented," Townsend said. "All of the results to date demonstrate that QuadraBlocs are safe, low in cost and remarkably effective in treating a large variety of aches and pains."

Townsend indicated that the product has not been approved by FDA, has been sold as an OTC product in 40 countries including the US and is not intended to obviate the need to seek professional assistance for health care professionals.

For more information about Gradient Medical and the QuadraBloc™, including laboratory results, videos, and testimonials, please visit www.QuadraBloc.com.

About Gradient Medical, LLC:
The owner of multiple patents for the design and use of QuadraBlocs, Gradient Medical, LLC is a pioneer in the field of using magnets for health. After AmWay's 10-year license of MagnaBloc expired in April of 2008, Gradient Medical launched the QuadraBloc, which offers non surgical and non drug alternatives for the management of pain. For more information about Gradient Medical's products, including the QuadraBloc, please visit http://www.QuadraBloc.com.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Quantum Group Adds New Insurance Product for Physicians
2. Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch, New Endurance Products SR L-Arginine and Grape Seed Extract
3. Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
4. Birchwood Laboratories Expands B-SURE™ Incontinence and Personal Care Product Line™; Three New Products Added Including B-SURE Fresh 'n Go™, B-SURE Bottom Balm™ and B-SURE Traveler™
5. Best Practice Database Adds Research on New Product Commercialization
6. StrionAir System A130 Air Purification Product Reduces Fan Energy by More Than 10 Percent
7. NSF International Certifies Purity of Four Mannatech Products
8. HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
9. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
10. Function Drinks Launches New Product to Support Sexual Health
11. Blue Cross and Blue Shield of Georgia Introduces New Individual Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Ga. (PRWEB) , ... April 24, 2017 , ... ... trusted advisor within the telehealth industry, announces the company’s VideoMedicine mobile platform has ... care providers. Available 24 hours a day, Quick Care provides patients with the ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management announced today ... people with addiction who are served by MAP’s patient engagement ecosystem. Lief Therapeutics ... monitors heart and breath rates to identify anxiety levels and can provide biofeedback ...
(Date:4/24/2017)... NJ (PRWEB) , ... April 24, 2017 , ... Come ... Plaza Hotel, 4200 Jim Walter Blvd, for an educational and exciting 2-day program. ... of our staff hearing this before they approach patients” about the course entitled Ain't ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... “Reflections of ... to God. “Reflections of God’s Work” is the creation of published author, Jerri Broglin, ... God’s comfort. , “I believe this a great eye-opener for those searching for ...
(Date:4/24/2017)... Florida (PRWEB) , ... April 24, 2017 , ... Life ... the University of Florida. The event will be held at 7:30 pm on May ... Ken Block and Drew Copeland of Sister Hazel, will support the UF Collegiate Recovery ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... , April 19, 2017 The ... Application, Forecast to 2022 report has covered and analysed the ... and information on market size, shares and growth factors. The ... drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
Breaking Medicine Technology: